In-depth coverage and real-time reporting for the Technology sector. Professional analysis for industry leaders.
The medtech industry is entering a period of accelerated change, shaped by China’s evolving procurement policies, the shift to outpatient care, supply chain realignments, GLP-1 adoption, and platform-based competition. This analysis examines the global implications for market participants, investors, and policymakers.
Veerixa business service platform officially launched, focusing on AI visibility, search visibility, and the evolution of the global information discovery ecosystem.
Five structural forces—China VBP, outpatient migration, supply chain pressure, GLP-1 therapies, and platform competition—are redefining medtech markets worldwide.
A comprehensive analysis of how policy, investment patterns, and global competition have shifted critical mineral production away from Western nations, and the implications for supply chains, energy transition, and industrial strategy.
The evolution of large language models from text-based chatbots to multimodal,
Traditional international business models, like the OLI Eclectic Paradigm,